Tạp chí Tim mạch học Việt Nam
<p>Trong phần này, bạn sẽ tìm thấy tất cả các chủ đề liên quan đến các can thiệp cho bệnh suy tim như suy tim cấp tính và suy tim mạn tính.</p>
Background: Many patients with heart failure (HF) with reduced ejection fraction (HFrEF) have improved or restored left ventricular ejection fraction (LVEF). Within context heart failure with recovered or improved ejecti...
Background: Heart failure continues to be a leading cause of hospitalization worldwide, and acute heart failure (AHF) poses a significant risk of morbidity and mortality in the short term1. Acute heart failure (AHF)is a...
Decongestion is an important primary goal in acute heart failure treatment. Loop diuretics remain a fundamental role in congestion management and symptom improvement in patients with acute heart failure. Diuretic combina...
Objectives: To evaluate the role of Hendry’s score based on the electrocardiogram in predicting heart failure with reduced ejection fraction. Methods: This is a cross-sectional study, including 91 inpatient heart failur...
Background: Heart failure is the consequence of many diseases that cause structural and/or functional disorders of the heart. Having a heart failure management program is essential to ensure patients receive optimal care...
Heart failure (HF) with reduced ejection fraction (HFrEF) is a complex clinical syndrome associated with high mortality, long hospital length of stay, high readmission rates, reduced exercise tolerance, and decreased qua...
Heart failure is a growing public health issue with high mortality and hospitalization rates. Comprehensive management programs are needed to improve outcomes and reduce costs. In Vietnam, there are gaps in guideline-dir...
Objective: Assess the perception of cardiologists, internists, and other specialties on the diagnosis and treatment of heart failure in Vietnam. Subjects and methods: Crosssectional study, on cardiologists, internists an...
Background: Tricuspid regurgitation severity has recently gained attention as a prognostic predictor of outcome events in patients who have leftsided heart failure. This study sought to define the relationship between tr...
Objective: Describe the characteristic and change of left ventricular systolic function after percutaneous coronary intervention in patients with chronic coronary syndrome and heart failure with reduced ejection fraction...
Background: Heart failure with preserved ejection fraction (HFpEF) carries a high risk of mortality and hospitalization, especially in patients with comorbid hypertension and type 2 diabetes mellitus. Little is known abo...
Background: Patients with heart failure with preserved ejection fraction (HFpEF) account for more than half of all heart failure patients. The most common method for assessing left ventricular diastolic dysfunction is ec...
Objectives: (1) To describe the characteristics and ELAN – HF score in hospitalized heart failure patients with reduced ejection fraction (HFrEF). (2) To evaluate external validation of the ELAN‐HF (European Collaboratio...
Angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor antagonists (ARBs) are commonly used in patients with CKD. This is based on large RCT trials and mount of epidermiology data. Even so, their val...
Introduction: Heart failure with reduced ejection fraction (HFrEF) and rapid atrial fibrillation often coexist, forming a vicious cycle that worsens hemodynamics. When pharmacologic therapy fails, the “pace and ablate” s...